Working...
ClinicalTrials.gov

Key Record Dates

ClinicalTrials.gov Identifier: NCT02042391
Brief Title: Risk-stratified Sequential Treatment of Post-transplant Lymphoproliferative Disease (PTLD) With Rituximab SC and Immunochemotherapy (PTLD-2)

First Submitted : January 20, 2014
First Submitted that Met QC Criteria : January 20, 2014
First Posted : January 22, 2014 (Estimate)

Last Update Submitted that Met QC Criteria : July 23, 2018
Last Update Posted : July 24, 2018